{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T12:57:39Z","timestamp":1788872259893,"version":"build-2803163510"},"reference-count":29,"publisher":"Begell House","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Crit Rev Eukaryot Gene Expr"],"published-print":{"date-parts":[[2025]]},"abstract":"<p>Gastric cancer (GC) is a highly prevalent malignancy with significant morbidity and mortality rates. N4-acetylcytidine (ac4C), an emerging RNA modification, has been implicated in tumorigenesis of GC. NAT10, an enzyme responsible for ac4C modification, has garnered attention for its potential role in cancer progression. This study investigates the role of NAT10 in GC. We analyzed NAT10 expression in GC tissues and cell lines using Rt-qPCR, immunohistochemistry and Western blotting. Functional studies were conducted using shRNA and overexpression models &lt;i&gt;in vitro&lt;\/i&gt; and &lt;i&gt;in vivo&lt;\/i&gt;. The molecular mechanisms underlying NAT10-mediated GRB7 regulation were elucidated through ac4C modification assays. Our findings revealed that NAT10 is overexpressed in GC tissues and cells and predicted poor prognosis of GC patients. Inhibition of NAT10 suppressed the proliferation, migration, and invasion of GC cells. Mechanistically, NAT10-mediated ac4C modification enhanced expression of GRB7 by promoting its mRNA stability. Overexpression of GRB7 antagonized the effects of NAT10 shRNA and promoted the malignant behaviors of GC. &lt;i&gt;In vivo&lt;\/i&gt; studies showed that NAT10 knockdown reduced tumor growth. Collectively, our study highlights the crucial roles of NAT10 and ac4C modification in GC progression through the regulation of GRB7. Therefore, targeting NAT10\/GRB7 axis may be a novel strategy for GC.\n<\/p>","DOI":"10.1615\/critreveukaryotgeneexpr.2025058741","type":"journal-article","created":{"date-parts":[[2025,4,11]],"date-time":"2025-04-11T15:56:47Z","timestamp":1744387007000},"page":"59-68","source":"Crossref","is-referenced-by-count":1,"title":["NAT10-Mediated N4-Acetylcytidine Modification of GRB7 Promotes the Progression of Gastric Cancer"],"prefix":"10.1615","volume":"35","author":[{"given":"Min","family":"Huang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhengrong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenwu","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhengwu","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinguo","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"613","reference":[{"key":"2","doi-asserted-by":"crossref","unstructured":"Smyth EC, Nilsson M, Grabsch HI, van Grieken NC, Lordick F. Gastric cancer. Lancet. 2020;396:635-48. doi: 10.1016\/S0140-6736(20)31288-5.","DOI":"10.1016\/S0140-6736(20)31288-5"},{"key":"3","doi-asserted-by":"crossref","unstructured":"Yasuda T, Wang YA. Gastric cancer immunosuppressive microenvironment heterogeneity: Implications for therapy development. Trends Cancer. 2024;10:627-2. doi: 10.1016\/j.trecan.2024.03.008.","DOI":"10.1016\/j.trecan.2024.03.008"},{"key":"4","doi-asserted-by":"crossref","unstructured":"Wang Z, Han W, Xue F, Zhao Y, Wu P, Chen Y, Yang C, Gu W, Jiang J. Nationwide gastric cancer prevention in China, 2021-2035: A decision analysis on effect, affordability and cost-effectiveness optimisation. Gut. 2022;71:2391-400. doi: 10.1136\/gutjnl-2021-325948.","DOI":"10.1136\/gutjnl-2021-325948"},{"key":"5","doi-asserted-by":"crossref","unstructured":"Yang L, Kartsonaki C, Yao P, de Martel C, Plummer M, Chapman D, Guo Y, Clark S, Walters RG, Chen Y, Pei P. The relative and attributable risks of cardia and non-cardia gastric cancer associated with Helicobacter pylori infection in China: A case-cohort study. Lancet Public Health. 2021;6(12):e888-96.","DOI":"10.1016\/S2468-2667(21)00164-X"},{"key":"6","doi-asserted-by":"crossref","unstructured":"Zeng Y, Jin RU. Molecular pathogenesis, targeted therapies, and future perspectives for gastric cancer. Semin Cancer Biol. 2022;86:566-82. doi: 10.1016\/j.semcancer.2021.12.004.","DOI":"10.1016\/j.semcancer.2021.12.004"},{"key":"7","doi-asserted-by":"crossref","unstructured":"Yu X, Zhang Y, Luo F, Zhou Q, Zhu L. The role of microRNAs in the gastric cancer tumor microenvironment. Mol Cancer. 2024;23:170. doi: 10.1186\/s12943-024-02084-x.","DOI":"10.1186\/s12943-024-02084-x"},{"key":"8","doi-asserted-by":"crossref","unstructured":"Cao T, Zhang W, Wang Q, Wang C, Ma W, Zhang C, Ge M, Tian M, Yu J, Jiao A, Wang L, Liu M, Wang P, Guo Z, Zhou Y, Chen S, Yin W, Yi J, Guo H, Han H, Zhang B, Wu K, Fan D, Wang X, Nie Y, Lu Y, Zhao X. Cancer SLC6A6-mediated taurine uptake transactivates immune checkpoint genes and induces exhaustion in CD8(+) T cells. Cell. 2024;187:2288-304 e2227. doi: 10.1016\/j. cell.2024.03.011.","DOI":"10.1016\/j.cell.2024.03.011"},{"key":"9","doi-asserted-by":"crossref","unstructured":"Barbieri I, Kouzarides T. Role of RNA modifications in cancer. Nat Rev Cancer. 2020;20:303-22. doi: 10.1038\/s41568-020-0253-2.","DOI":"10.1038\/s41568-020-0253-2"},{"key":"10","doi-asserted-by":"crossref","unstructured":"Wang Q, Yuan Y, Zhou Q, Jia Y, Liu J, Xiao G, Li C, Jiang X. RNA N4-acetylcytidine modification and its role in health and diseases. MedComm. 2025;6:e70015. doi: 10.1002\/mco2.70015.","DOI":"10.1002\/mco2.70015"},{"key":"11","doi-asserted-by":"crossref","unstructured":"Liao L, He Y, Li SJ, Yu XM, Liu ZC, Liang YY, Yang H, Yang J, Zhang GG, Deng CM, Wei X, Zhu YD, Xu TY, Zheng CC, Cheng C, Li A, Li ZG, Liu JB, Li B. Lysine 2-hydroxyisobutyrylation of NAT10 promotes cancer metastasis in an ac4C-dependent manner. Cell Res. 2023;33:355-71. doi: 10.1038\/s41422-023-00793-4.","DOI":"10.1038\/s41422-023-00793-4"},{"key":"12","doi-asserted-by":"crossref","unstructured":"Jin C, Wang T, Zhang D, Yang P, Zhang C, Peng W, Jin K, Wang L, Zhou J, Peng C, Tan Y, Ji J, Chen Z, Sun Q, Yang S, Tang J, Feng Y, Sun Y. Acetyltransferase NAT10 regulates the Wnt\/beta-catenin signaling pathway to promote colorectal cancer progression via ac(4)C acetylation of KIF23 mRNA. J Exp Clin Cancer Res. 2022;41:345. doi: 10.1186\/s13046-022-02551-7.","DOI":"10.1186\/s13046-022-02551-7"},{"key":"13","doi-asserted-by":"crossref","unstructured":"Xie R, Cheng L, Huang M, Huang L, Chen Z, Zhang Q, Li H, Lu J, Wang H, Zhou Q, Huang J, Chen X, Lin T. NAT10 drives cisplatin chemoresistance by enhancing ac4C-associated DNA repair in bladder cancer. Cancer Res. 2023;83:1666-83. doi: 10.1158\/0008-5472.CAN-22-2233.","DOI":"10.1158\/0008-5472.CAN-22-2233"},{"key":"14","doi-asserted-by":"crossref","unstructured":"Chen C, Wang Z, Lin Q, Li M, Xu L, Fu Y, Zhao X, Ma Z, Xu J, Zhou S, Zhang M, Qian Y, Bao L, Wang B, Wang M, Ding Q, Wang Q, Wang S. NAT10 promotes gastric cancer liver metastasis by modulation of m2 macrophage polarization and metastatic tumor cell hepatic adhesion. Adv Sci. 2025:e2410263. doi: 10.1002\/advs.202410263.","DOI":"10.1002\/advs.202410263"},{"key":"15","doi-asserted-by":"crossref","unstructured":"Liu D, Yang X, Wang X. Neutrophil extracellular traps promote gastric cancer cell metastasis via the NAT10-mediated N4-acetylcytidine modification of SMYD2. Cell Signal. 2024;116:111014. doi: 10.1016\/j.cellsig.2023.111014.","DOI":"10.1016\/j.cellsig.2023.111014"},{"key":"16","doi-asserted-by":"crossref","unstructured":"Chu PY, Tai YL, Shen TL. Grb7, a critical mediator of EGFR\/ErbB signaling, in cancer development and as a potential therapeutic target. Cells. 2019;8.","DOI":"10.3390\/cells8050435"},{"key":"17","doi-asserted-by":"crossref","unstructured":"Wang G, Wu Y, Su Y, Qu N, Chen B, Zhou D, Yuan L, Yin M, Liu M, Zhou W. TCF12-regulated GRB7 facilitates the HER2+ breast cancer progression by activating Notch1 signaling pathway. J Transl Med. 2024;22:745. doi: 10.1186\/s12967-024-05536-6.","DOI":"10.1186\/s12967-024-05536-6"},{"key":"18","doi-asserted-by":"crossref","unstructured":"Gotovac JR, Liu DS, Yates MJ, Milne JV, Macpherson AA, Simpson KJ, Eslick GD, Mitchell C, Duong CP, Phillips WA, Clemons NJ. GRB7 is an oncogenic driver and potential therapeutic target in oesophageal adenocarcinoma. J Pathol. 2020;252:317-29.","DOI":"10.1002\/path.5528"},{"key":"19","doi-asserted-by":"crossref","unstructured":"Pei YY, Ran J, Wen L, Liu X, Xiang L, Liu W, Wei F. Up-regulated GRB7 protein in gastric cancer cells correlates with clinical properties and increases proliferation and stem cell properties. Front Oncol. 2022;12:1054976. doi: 10.3389\/fonc.2022.1054976","DOI":"10.3389\/fonc.2022.1054976"},{"key":"20","doi-asserted-by":"crossref","unstructured":"Wei W, Zhang S, Han H, Wang X, Zheng S, Wang Z, Yang C, Wang L, Ma J, Guo S, Wang J, Liu L, Choe J, Lin S. NAT10-mediated ac4C tRNA modification promotes EGFR mRNA translation and gefitinib resistance in cancer. Cell Rep. 2023;42:112810.","DOI":"10.1016\/j.celrep.2023.112810"},{"key":"21","doi-asserted-by":"crossref","unstructured":"Galassi C, Chan TA, Vitale I, Galluzzi L. The hallmarks of cancer immune evasion. Cancer Cell. 2024;42:1825-63. doi: 10.1016\/j.ccell.2024.09.010.","DOI":"10.1016\/j.ccell.2024.09.010"},{"key":"22","doi-asserted-by":"crossref","unstructured":"Wang Q, Li M, Chen C, Xu L, Fu Y, Xu J, Shu C, Wang B, Wang Z, Chen C, Song T, Wang S. Glucose homeostasis controls N-acetyltransferase 10-mediated ac4C modification of HK2 to drive gastric tumorigenesis. Theranostics. 2025;15:2428-50.","DOI":"10.7150\/thno.104310"},{"key":"23","doi-asserted-by":"crossref","unstructured":"Liu S, Lin C, Lin X, Lin P, He R, Pan X, Lin Y, Ye J, Zhu G. NAT10 Phase separation regulates YTHDF1 splicing to promote gastric cancer progression. Cancer Res. 2024;84:3207-22. doi: 10.1158\/0008-5472.CAN-23-4062.","DOI":"10.1158\/0008-5472.CAN-23-4062"},{"key":"24","doi-asserted-by":"crossref","unstructured":"Song S, Li B, Jin X, Li H, Wang H, Wang F, He Y, Zhang C. NAT10 Overexpression promotes tumorigenesis and epithelial-mesenchymal transition through AKT pathway in gastric cancer. Dig Dis Sci. 2024;69:3261-75. doi: 10.1007\/s10620-024-08472-z.","DOI":"10.1007\/s10620-024-08472-z"},{"key":"25","doi-asserted-by":"crossref","unstructured":"Deng M, Zhang L, Zheng W, Chen J, Du N, Li M, Chen W, Huang Y, Zeng N, Song Y, Chen Y. Helicobacter pylori-induced NAT10 stabilizes MDM2 mRNA via RNA acetylation to facilitate gastric cancer progression. J Exp Clin Cancer Res. 2023;42:9.","DOI":"10.1186\/s13046-022-02586-w"},{"key":"26","doi-asserted-by":"crossref","unstructured":"Liu R, Wubulikasimu Z, Cai R, Meng F, Cui Q, Zhou Y, Li Y. NAT10-mediated N4-acetylcytidine mRNA modification regulates self-renewal in human embryonic stem cells. Nucleic Acids Res. 2023;51:8514-31. doi: 10.1093\/nar\/gkad628.","DOI":"10.1093\/nar\/gkad628"},{"key":"27","doi-asserted-by":"crossref","unstructured":"Yang Q, Lei X, He J, Peng Y, Zhang Y, Ling R, Wu C, Zhang G, Zheng B, Chen X, Zou B, Fu Z, Zhao L, Liu H, Hu Y, Yu J, Li F, Ye G, Li G. N4-acetylcytidine drives glycolysis addiction in gastric cancer via NAT10\/SEPT9\/HIF-1alpha positive feedback loop. Adv Sci. 2023;10:e2300898. doi: 10.1002\/advs.202300898.","DOI":"10.1002\/advs.202300898"},{"key":"28","doi-asserted-by":"crossref","unstructured":"Zhang Y, Jing Y, Wang Y, Tang J, Zhu X, Jin WL, Wang Y, Yuan W, Li X, Li X. NAT10 promotes gastric cancer metastasis via N4-acetylated COL5A1. Signal Transduct Target Ther. 2021;6:173. doi: 10.1038\/s41392-021-00489-4.","DOI":"10.1038\/s41392-021-00489-4"},{"key":"29","doi-asserted-by":"crossref","unstructured":"Zhu G, Cai H, Xiao Q, Zeng S, Jiang X, Liu D. GRB7 plays a promoting role in the progression of gastric cancer. BMC Cancer. 2023;23:1262. doi: 10.1186\/s12885-023-11694-5","DOI":"10.1186\/s12885-023-11694-5"},{"key":"30","doi-asserted-by":"crossref","unstructured":"Wang Z, Wang Y, He Y, Zhang N, Chang W, Niu Y. Aquaporin-1 facilitates proliferation and invasion of gastric cancer cells via GRB7-mediated ERK and Ras activation. Anim Cells Syst. 2020;24:253-9. doi: 10.1080\/19768354.2020.1833985.","DOI":"10.1080\/19768354.2020.1833985"}],"container-title":["Critical Reviews in Eukaryotic Gene Expression"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.dl.begellhouse.com\/download\/article\/29cb94d55b72fa81\/CRE-58741.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,24]],"date-time":"2025-06-24T05:38:50Z","timestamp":1750743530000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.dl.begellhouse.com\/journals\/6dbf508d3b17c437,3f752e004be8e7df,29cb94d55b72fa81.html"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025]]},"references-count":29,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1615\/critreveukaryotgeneexpr.2025058741","relation":{},"ISSN":["1045-4403"],"issn-type":[{"value":"1045-4403","type":"print"}],"subject":[],"published":{"date-parts":[[2025]]}}}